| Name | St Augustine Manor |
|---|---|
| Location | 7801 Detroit Ave, Cleveland, Ohio |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 234 |
| Occupancy Rate | 81.37% |
| Medicare ID (CCN) | 365883 |
| Legal Business Name | St Augustine Manor |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1154586287 |
| Organization Name | ST AUGUSTINE SERVICES CORP |
| Address | 7801 Detroit Ave, Cleveland, OH 44102 |
| Phone Number | 216-939-7609 |
News Archive
The pharmaceutical company Merck on Monday named former CDC head Julie Gerberding as president of the company's vaccine division, Reuters reports. "Gerberding, who led the CDC from 2002 to 2009 and stepped down when President Barack Obama took office, will head up the company's $5 billion global vaccine business that includes shots to prevent chickenpox, cervical cancer and pneumonia," the news service reports.
Amgen today announced that the U.S. Food and Drug Administration (FDA) approved two new indications for Prolia® (denosumab) as a treatment to increase bone mass in women at high risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer and as a treatment to increase bone mass in men at high risk for fracture receiving androgen deprivation therapy for non-metastatic prostate cancer.
In what they are calling a new direction in the study of Alzheimer's disease, UC Santa Barbara scientists have made an important finding about what happens to brain cells that are destroyed in Alzheimer's disease and related dementias.
A platform that can diagnose several diseases with a high degree of precision using metabolic markers found in patients' blood has been developed by scientists at the University of Campinas in Brazil
› Verified 2 days ago
| NPI Number | 1235128034 |
| Organization Name | ST. AUGUSTINE SERVICES CORP. |
| Address | 7801 Detroit Ave, Cleveland, OH 44102 |
| Phone Number | 216-634-7425 |
News Archive
The pharmaceutical company Merck on Monday named former CDC head Julie Gerberding as president of the company's vaccine division, Reuters reports. "Gerberding, who led the CDC from 2002 to 2009 and stepped down when President Barack Obama took office, will head up the company's $5 billion global vaccine business that includes shots to prevent chickenpox, cervical cancer and pneumonia," the news service reports.
Amgen today announced that the U.S. Food and Drug Administration (FDA) approved two new indications for Prolia® (denosumab) as a treatment to increase bone mass in women at high risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer and as a treatment to increase bone mass in men at high risk for fracture receiving androgen deprivation therapy for non-metastatic prostate cancer.
In what they are calling a new direction in the study of Alzheimer's disease, UC Santa Barbara scientists have made an important finding about what happens to brain cells that are destroyed in Alzheimer's disease and related dementias.
A platform that can diagnose several diseases with a high degree of precision using metabolic markers found in patients' blood has been developed by scientists at the University of Campinas in Brazil
› Verified 2 days ago
| NPI Number | 1396883591 |
| Organization Name | ST AUGUSTINE MANOR |
| Doing Business As | ST AUGUSTINE MANOR DBA HOLY FAMILY HOME |
| Address | 7801 Detroit Avenue, Cleveland, OH 44102 |
| Phone Number | 216-634-7400 |
News Archive
The pharmaceutical company Merck on Monday named former CDC head Julie Gerberding as president of the company's vaccine division, Reuters reports. "Gerberding, who led the CDC from 2002 to 2009 and stepped down when President Barack Obama took office, will head up the company's $5 billion global vaccine business that includes shots to prevent chickenpox, cervical cancer and pneumonia," the news service reports.
Amgen today announced that the U.S. Food and Drug Administration (FDA) approved two new indications for Prolia® (denosumab) as a treatment to increase bone mass in women at high risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer and as a treatment to increase bone mass in men at high risk for fracture receiving androgen deprivation therapy for non-metastatic prostate cancer.
In what they are calling a new direction in the study of Alzheimer's disease, UC Santa Barbara scientists have made an important finding about what happens to brain cells that are destroyed in Alzheimer's disease and related dementias.
A platform that can diagnose several diseases with a high degree of precision using metabolic markers found in patients' blood has been developed by scientists at the University of Campinas in Brazil
› Verified 2 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
The pharmaceutical company Merck on Monday named former CDC head Julie Gerberding as president of the company's vaccine division, Reuters reports. "Gerberding, who led the CDC from 2002 to 2009 and stepped down when President Barack Obama took office, will head up the company's $5 billion global vaccine business that includes shots to prevent chickenpox, cervical cancer and pneumonia," the news service reports.
Amgen today announced that the U.S. Food and Drug Administration (FDA) approved two new indications for Prolia® (denosumab) as a treatment to increase bone mass in women at high risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer and as a treatment to increase bone mass in men at high risk for fracture receiving androgen deprivation therapy for non-metastatic prostate cancer.
In what they are calling a new direction in the study of Alzheimer's disease, UC Santa Barbara scientists have made an important finding about what happens to brain cells that are destroyed in Alzheimer's disease and related dementias.
A platform that can diagnose several diseases with a high degree of precision using metabolic markers found in patients' blood has been developed by scientists at the University of Campinas in Brazil
› Verified 2 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 1 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 14.81 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 9.52 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 57.33 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 3.66 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 2.26 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 1.92 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0.7 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 1.27 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.3 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 13.11 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 93.17 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 3.74 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 33.43 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 14.68 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 16.24 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 96.82 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 69.83 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 84.92 | 82.93 |
News Archive
The pharmaceutical company Merck on Monday named former CDC head Julie Gerberding as president of the company's vaccine division, Reuters reports. "Gerberding, who led the CDC from 2002 to 2009 and stepped down when President Barack Obama took office, will head up the company's $5 billion global vaccine business that includes shots to prevent chickenpox, cervical cancer and pneumonia," the news service reports.
Amgen today announced that the U.S. Food and Drug Administration (FDA) approved two new indications for Prolia® (denosumab) as a treatment to increase bone mass in women at high risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer and as a treatment to increase bone mass in men at high risk for fracture receiving androgen deprivation therapy for non-metastatic prostate cancer.
In what they are calling a new direction in the study of Alzheimer's disease, UC Santa Barbara scientists have made an important finding about what happens to brain cells that are destroyed in Alzheimer's disease and related dementias.
A platform that can diagnose several diseases with a high degree of precision using metabolic markers found in patients' blood has been developed by scientists at the University of Campinas in Brazil
› Verified 2 days ago
Franklin Plaza Extended Care Location: 3600 Franklin Boulevard, Cleveland, Ohio 44113 Phone: (216) 651-1600 | |
Rocky River Gardens Rehab And Nursing Ctr Location: 4102 Rocky River Dr, Cleveland, Ohio 44135 Phone: (216) 251-3300 | |
Euclid Beach Healthcare Location: 16101 Euclid Beach Blvd, Cleveland, Ohio 44110 Phone: (216) 486-2300 |